Product Information
AMLODIPINE-ATORVAST 5-20 MG is a generic product labeled by Apotex Corp., priced at $0.8590 per EA under NDC 60505348303. Its NADAC has been published 310 times since Sep 16, 2020.
FDA first approved this application on Nov 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 20 mg/1; mg/1
Manufacturer
Apotex Corp.NDC
60505348303
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205199FDA Approved
11/18/2019
TE Code
AB
On Market Since
7/29/2020
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 5-20 MG has been published 310 times since Sep 16, 2020, and over the history we have for it it has declined 67.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8590 per EA |
|---|---|
| All-time high | $3.5336 (Nov 11, 2020) |
| All-time low | $0.5996 (May 21, 2025) |
| 52-week high | $1.0813 |
| 52-week low | $0.7544 |
| Median price | $1.5427 |
| Average price | $1.6437 |
| Largest weekly change | +57.2% (Sep 22, 2021) |
| Weeks tracked | 310 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-20 MG, manufactured by Apotex Corp., is $0.8590 per EA (NDC 60505348303), effective Aug 19, 2026.
How has the price of AMLODIPINE-ATORVAST 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-20 MG has declined 67.7%. It has been tracked across 310 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-20 MG?
Since Sep 16, 2020, the NADAC for AMLODIPINE-ATORVAST 5-20 MG has ranged from a low of $0.5996 (May 21, 2025) to a high of $3.5336 (Nov 11, 2020), with a median of $1.5427 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-20 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 5-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 5-20 MG?
AMLODIPINE-ATORVAST 5-20 MG (NDC 60505348303) is labeled by Apotex Corp., and CMS classifies it as a generic product.